Cognita Imaging
Stanford-founded radiology AI startup providing diagnostic imaging interpretation with FDA breakthrough designation, now acquired by Radiology Partners.
Pros
- FDA Breakthrough Device designation for chest X-ray analysis
- reads 76% faster than radiologists while increasing disease detection by 52%
- strong clinical validation with multi-site deployment
Cons
- Website currently unavailable (ENOTFOUND)
- no independent pricing available
- now proprietary to Radiology Partners post-acquisition
Cost
Pricing is not published; contact the vendor for a quote. The site is live but reads as a mission and roadmap page for expanding radiology access, with no plan tiers and no amounts.
Verdict
Best for radiology departments integrated with or considering Radiology Partners' ecosystem; strong clinical validation but now requires enterprise relationship.
Visit Cognita Imaging